Method for predicting the response to a treatment against hepatitis c

Sylvain Lehmann (1) , Stéphane Roche (2, 1) , Jacques Ducos , Laurent Tiers (1)

1 PPM - Pôle Protéome de Montpellier
2 GMGF - Génétique Médicale et Génomique Fonctionnelle

The invention relates to a method for predicting the response to an interferon-based treatment in a patient infected with hepatitis C virus. This method consists in determining the presence of apolipoprotein CIII and/or of a multimeric form of human serum albumin in a sample of biological fluid from the patient.

Mots clés: Hepatite C; Biomarqueur; Traitement

Domaines: Biotechnologies; Biochimie [q-bio.BM]

Sylvain Lehmann, Stéphane Roche, Jacques Ducos, Laurent Tiers. Method for predicting the response to a treatment against hepatitis c. United States, Patent n° : US 2014/0051079 A1. 2014. ⟨hal-01899413⟩